Sone Capital Management LLC Invests $27.75 Million in The Cooper Companies, Inc. $COO

Sone Capital Management LLC acquired a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 387,030 shares of the medical device company’s stock, valued at approximately $27,754,000. Cooper Companies accounts for about 2.1% of Sone Capital Management LLC’s investment portfolio, making the stock its 9th largest holding.

Several other hedge funds have also recently added to or reduced their stakes in COO. BlackRock Inc. bought a new position in Cooper Companies during the second quarter worth about $1,077,762,000. State Street Corp increased its stake in shares of Cooper Companies by 2.4% in the 4th quarter. State Street Corp now owns 8,793,747 shares of the medical device company’s stock valued at $720,736,000 after acquiring an additional 207,195 shares during the last quarter. Wellington Management Group LLP raised its position in shares of Cooper Companies by 332.9% in the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock valued at $424,043,000 after acquiring an additional 4,756,178 shares during the period. Price T Rowe Associates Inc. MD raised its position in shares of Cooper Companies by 58.8% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock valued at $494,123,000 after acquiring an additional 2,231,568 shares during the period. Finally, Generation Investment Management LLP bought a new position in Cooper Companies during the 2nd quarter worth approximately $356,304,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Wall Street Analyst Weigh In

COO has been the subject of a number of analyst reports. JPMorgan Chase & Co. decreased their price objective on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a report on Friday, June 5th. Mizuho set a $85.00 price target on shares of Cooper Companies and gave the stock an “outperform” rating in a research report on Thursday, June 4th. Citigroup reissued a “neutral” rating and issued a $80.00 price target (up from $76.00) on shares of Cooper Companies in a report on Thursday, August 13th. Stifel Nicolaus lowered their price objective on shares of Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a research report on Friday, June 5th. Finally, Robert W. Baird dropped their price objective on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating on the stock in a research note on Friday, June 5th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $81.64.

Cooper Companies Stock Down 0.6%

Shares of COO stock opened at $75.80 on Tuesday. The Cooper Companies, Inc. has a 12-month low of $58.89 and a 12-month high of $89.83. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23. The firm has a fifty day moving average of $72.09 and a 200-day moving average of $71.07. The company has a market capitalization of $14.78 billion, a price-to-earnings ratio of 64.24, a P/E/G ratio of 1.99 and a beta of 0.83.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. The firm had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The company’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same period in the prior year, the business earned $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, equities research analysts predict that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.